Oct 28Yahoo! News: A Nasal COVID-19 Vaccine Could Be the Solution to Ending the Pandemic, Experts Say
Oct 28Meissa Announces Positive Preliminary Clinical Data on Safety and Immunogenicity of Intranasal COVID
Jul 19Preclinical Data on Intranasal COVID-19 Vaccine Shows Protection from SARS-CoV-2 after Single Dose
Jul 19Big4Bio Podcast: How a Long Effort to Protect Against RSV May Lead to a Better COVID-19 Vaccine
Mar 25BioSpace: Meissa’s Intranasal COVID-19 Vaccine Uses Codon Deoptimization for Stronger Responses
Mar 16Meissa Announces IND Clearance for Phase 1 Study of COVID-19 Intranasal Live Attenuated Vaccine
Jan 21Meissa Announces 1st Dosing in Phase 2 Study of Intranasal Live Attenuated Vaccine Candidate for RSV
Oct 14, 2020Meissa Vaccines Expands Leadership Team as Company Advances Intranasal RSV and COVID-19 Candidates
Jul 30, 2020Covid Vaccine Player Emerges on the Peninsula with Hopes of Starting Clinical Trial Early Next Year
Jul 20, 2020BioSpace: Another COVID-19 Vaccine Joins the Race – This Time, it’s a Live, Weakened Virus
